Clinical Trial Update: Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization [NA]

View source ↗

Summary

A randomized study evaluated photodynamic therapy with dihematoporphyrin for corneal neovascularization; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization

Drugs mentioned

• Dihematoporphyrin (dihematoporphyrin)

Snippet

Sponsor: Medical College of Hampton Roads | Conditions: Corneal Neovascularization | NA | Status: COMPLETED